(Q45405259)

14 December 2017

Longer survival of liver transplant recipients with hepatitis virus coinfections (English)

1 reference

14 December 2017

6

Michael P Manns

1 reference

14 December 2017

2

Heiner Wedemeyer

1 reference

14 December 2017

4

Jürgen Klempnauer

1 reference

14 December 2017

Kinan Rifai

1

1 reference

14 December 2017

Jens Rosenau

series ordinal

3

1 reference

14 December 2017

Christian P Strassburg

series ordinal

5

1 reference

14 December 2017

Hans L Tillmann

series ordinal

7

1 reference

14 December 2017

1 March 2007

1 reference

14 December 2017

Clinical Transplantation

1 reference

14 December 2017

21

1 reference

14 December 2017

258-264

1 reference

14 December 2017

2

1 reference

Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients.

14 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Infection with GB virus C and reduced mortality among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

HIV-1 suppression during acute scrub-typhus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Epidemiology and clinical outcome of hepatitis D virus infection in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Outcome of liver transplantation for hepatitis B in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Long-term outcome of hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Liver transplantation and HBsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Characteristics of patients with dual infection by hepatitis B and C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Influence of chronic coinfection with hepatitis B and C virus on liver histology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Predictors of patient and graft survival following liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00636.X

10.1111/J.1399-0012.2006.00636.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference